In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the…
NEW YORK (Reuters Health) – New research supports current clinical guidance to perform partial nephrectomy (PN) when possible in patients with clinically organ-confined renal cell tumors 7 centimeters…
NEW YORK (Reuters Health) – Most patients with allergic reactions to clopidogrel do not need to stop the drug or switch to another antiplatelet drug but rather can…
NEW YORK (Reuters Health) – A simple ultrasound examination of the femoral artery puncture site before elective percutaneous coronary intervention decreases the rate of subsequent vascular complications, a…
NEW YORK (Reuters Health) – For preventing relapse of ulcerative colitis (UC), mesalamine can be taken once a day rather than twice or three times daily, according to…
NEW YORK (Reuters Health) – For patients with a limited number of brain metastases, treatment with stereotactic radiosurgery alone is as good as whole-brain radiotherapy plus stereotactic radiosurgery…
NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral…
NEW YORK (Reuters Health) – Treating patients with pulmonary arterial hypertension with more than one class of pulmonary vasodilator does not decrease mortality or slow progression of the…
NEW YORK (Reuters Health) – Preterm infants requiring respiratory support do not benefit from inhaled nitric oxide (iNO), according to the results of a meta-analysis of individual patient…
NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an…
